Better Buy: GlaxoSmithKline vs. Bristol-Myers Squibb

Big pharma has been an outstanding space for investors over the past five years. In fact, every single big pharma company outperformed the broader biopharmaceutical industry during this period in terms of total returns on capital, including dividends and"